Skip to content

Novigenix SA vs SENSEERA

Novigenix SA logo

Novigenix SA

Leader in Immuno-Transcriptomic Precision Medicine solutions

26 employees · est. 2014 · Lausanne, Switzerland

VS
SENSEERA logo

SENSEERA

Empowering diagnostics and drug development with AI-driven chromatin liquid biopsy

20 employees · est. 2020 · Jerusalem, Israel

Novigenix SA is the older company (2014 vs 2020).

Side-by-Side Comparison

Novigenix SA SENSEERA
Founded
2014 older 2020
Headquarters
Lausanne, Switzerland Jerusalem, Israel
Employees
26 20
Industry
AI, Analytics, Biotechnology Health Care
Funding Stage
Series B Not tracked yet
Total Funding
$21.00M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Not tracked yet AI-driven chromatin liquid biopsy, Diagnostic platform for disease monitoring, Non-invasive gene expression analysis, Biomarker generation for treatment monitoring
Target Customers
Not tracked yet Pharmaceutical companies, Biotechnology firms, Clinical researchers, Healthcare providers, Diagnostic laboratories
Taxonomy
Precision MedicineImmunoTranscriptomicsAI In HealthcareCancer ManagementMulti-omics Data AnalysisTherapy Optimization +7 AI-driven DiagnosticsChromatin Liquid BiopsyBiomarker DiscoveryGenomic Expression MapsCell-free DNA AnalysisTissue-agnostic MRD Detection +9
Website
novigenix.com senseerahealth.com
Novigenix SA logo

About Novigenix SA

NOVIGENIX is a Swiss precision medicine company founded in 2014 that focuses on leveraging ImmunoTranscriptomic technologies to revolutionize disease management, with a primary focus on cancer. Through their proprietary LITOseek platform, which incorporates advanced Machine Learning and artificial i...

SENSEERA logo

About SENSEERA

SENSEERA is a promising player in the Health Care sector, founded in 2020 and based in Israel. The company is pioneering advancements in diagnostics and drug development with its AI-driven chromatin liquid biopsy technology. The foundation of SENSEERA's innovation is its patented GEM (Genomic Expre...

Also comparing in this category

Comparing more than these two?

Get Novigenix SA, SENSEERA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Novigenix SA compare?

A PDF of Novigenix SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Novigenix SA was founded in 2014, based in Lausanne, Switzerland, with 26 employees. NOVIGENIX is a Swiss precision medicine company founded in 2014 that focuses on leveraging ImmunoTranscriptomic technologies to revolutionize disease management, with a primary focus on cancer. Throug. SENSEERA was founded in 2020, based in Jerusalem, Israel, with 20 employees. SENSEERA is a promising player in the Health Care sector, founded in 2020 and based in Israel. The company is pioneering advancements in diagnostics and drug development with its AI-driven chromatin l.
Novigenix SA has raised $21.00M and SENSEERA no disclosed funding. Latest stage: Novigenix SA Series B.
Both work in Health Care and list precision medicine among their focus areas.

Compare Novigenix SA with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Novigenix SA on 11 Sep 2024, and SENSEERA on 5 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout